The amount of circulating biomarkers can be changed in vulnerable CS as a causal factor of atherosclerosis (lipid-related and lipoprotein biomarkers [15], MDA [16]), or it can be diffused from a carotid plaque that becomes vulnerable (apolipoprotein J, E, microRNA [15], etc.). Here, CLU is linked to atherosclerosis.